Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Anand Mehra files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Braden Michael Leonard - $1.36M in ACRS purchases and sales in the last 12 months
- Harry Shuman - $960K in MRUS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anand Mehra?
Anand Mehra is a corporate insider of Aclaris Therapeutics, Inc. (ACRS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Anand Mehra last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 3 filings going back to 2024.
Has Anand Mehra been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1.50M) and 0 open-market sales across all tracked filings.
